Anzeige
Mehr »
Login
Dienstag, 27.02.2024 Börsentäglich über 12.000 News von 684 internationalen Medien
Nurexone Biologic: Prof. Levenberg erklärt, wie die ExoTherapy funktioniert!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 865607 | ISIN: US2941001024 | Ticker-Symbol: EZB
Frankfurt
27.02.24
08:25 Uhr
1,210 Euro
-0,040
-3,20 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ENZO BIOCHEM INC Chart 1 Jahr
5-Tage-Chart
ENZO BIOCHEM INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,2201,25014:36
1,2201,25014:36

Aktuelle News zur ENZO BIOCHEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.02.Enzo Biochem, Inc.: Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments168FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company"), a leading life science company, announced the voting results from its Annual Meeting held...
► Artikel lesen
01.02.ENZO BIOCHEM INC - 8-K, Current Report-
15.12.23ENZO BIOCHEM INC - 10-Q, Quarterly Report2
28.11.23ENZO BIOCHEM INC - 10-K/A, Annual Report1
06.11.23Enzo Biochem GAAP EPS of $0.411
03.11.23ENZO BIOCHEM INC - 10-K, Annual Report1
30.10.23ENZO BIOCHEM INC - 8-K, Current Report2
30.10.23Enzo Biochem, Inc.: Steven J. Pully Appointed to Enzo Biochem's Board of Directors2
06.09.23Enzo Biochem names interim CEO1
06.09.23Enzo Biochem, Inc.: Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO262FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors...
► Artikel lesen
24.07.23Enzo Biochem, Inc.: Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp607Significant value unlocked for Enzo shareholders with continued focus on life sciences. FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has...
► Artikel lesen
15.06.23Enzo Biochem, Inc.: Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results493- Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23 FARMINGDALE, NY, June 14, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a pioneering biosciences...
► Artikel lesen
22.05.23Enzo Biochem, Inc.: Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale355FARMINGDALE, NY, May 22, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), announced today that the preliminary voting results from the Inspector of Election at today's Special Meeting of the...
► Artikel lesen
21.03.23Enzo Biochem, Inc.: Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results261- Company entered into an Asset Purchase Agreement for substantially all of the operating assets of the Clinical Labs division - Enzo Life Sciences reports revenue of $7.5 million, with Jan-23 revenue...
► Artikel lesen
17.03.23Pre-market Movers: Enzo Biochem, HUB Cyber Security, Sarepta Therapeutics, Monopar Therapeutics, ThermoGenesis1.016MEMPHIS (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.00 A.M. ET).In the GreenEnzo Biochem, Inc. (ENZ) is up over 81% at $2.16. HUB...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1